J&J submits gastric band PMA
This article was originally published in The Gray Sheet
Johnson & Johnson's Ethicon Endo-Surgery subsidiary files a PMA application April 9 for its laparoscopic adjustable gastric band to treat morbid obesity. The FDA submission includes a 276-patient, multi-center, single-arm study examining patients' percent weight loss three years after band placement. The device, marketed outside the United States as the Swedish Adjustable Gastric Band since 1996, is used in 25,000 procedures each year, according to Ethicon. Allergan's Lap-Band, FDA approved in 2001, is the only laparoscopic adjustable gastric band available in the United States (1"The Gray Sheet" March 19, 2007, p. 14)...
You may also be interested in...
CMS' decision to cover Allergan's Lap-Band laparoscopic adjustable gastric band for Medicare beneficiaries last February helped spark a 33% revenue jump for Allergan's obesity intervention business in 2006
COVID-19 Vaccines: ACIP’s Allocation Proposal Prioritizes Long-Term Care Residents, Essential Workers
First group to receive vaccine would comprise health care personnel and residents of long-term care facilities; next in line are non-health care essential workers, who would take priority over adults with high-risk medical conditions and those ages 65 years and older, according to the CDC advisory committee’s proposed allocation framework.
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.